AI assistant
Sending…
Vicore Pharma Holding — Major Shareholding Notification 2026
May 11, 2026
3211_rns_2026-05-11_571a7fa3-c803-424a-aebf-fb8abcae6905.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
Börsinformation
| Issuer | Vicore Pharma Holding AB |
Holder
| The Capital Group Companies, Inc. |
| Instrument |
| --- | --- |
| Instrument | Common Stock SE0007577895 |
| Before the transaction |
| Shares | 13,694,420 |
| Voting rights | 13,694,420 |
| Transaction |
| Reason for major shareholding notification | Buy |
| Date | 07/05/2026 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction |
| Quantity |
| Shares | 16,777,449 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 16,777,449 |
| Percentage |
| Directly held shares | 5.95948 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 5.95948 % |
| Resulting distribution of total holdings | |||
| Percentage of voting rights: | Number of underlying shares: | ||
| Shares | 5.95948 % | 16,777,449 | |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 | |||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 | |||
| - | Physically settled | ||
| - | Cash settled | ||
| Total | 5.95948 % | 16,777,449 | |
| Chain of controlling companies | ||
| Voting rights | % Voting rights | Company |
| 16,777,449 | 5.95948 | Capital Research and Management Company |
| Group total holdings | |
| Voting rights | 16,777,449 |
| Percentage of voting rights | 5.95948 |
| Notes (other relevant informations according to law) |
|---|
| ISIN: SE0007577895 SE0022760468 |
| Published |
| 11/05/2026 09:08 |
| Contact | |||
| Phone* | *** | Email* | *** |
| *) | Note that neither phone nor email is published on fi.se | |
| The legal basis for FI to compile and publish these so-called major shareholding notification announcements is that this document is necessary for FI to carry out a task in the public interest (Article 6(1)(e) of the General Data Protection Regulation). Chapter 4 of Act (1991:980) sets forth that major shareholders are obligated under certain conditions to notify FI when buying or selling shares and that FI must disclose this information. Chapter 12, sections 10–11 of FFFS 2007:17 specifies the required content of the major shareholding notification. Read more about FI’s processing of personal data here www.fi.se/sv/om-fi/dataskydd-och-behandling-av-personuppgifter-pa-fi/ |
| [email protected] | Tfn 08-408 980 37 | Fax 08-24 39 25 |
More from Vicore Pharma Holding
AGM Information
2026
May 6
AGM Information
2026
May 6
Proxy Solicitation & Information Statement
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Annual Report (ESEF)
2026
Mar 26
Share Issue/Capital Change
2025
Nov 28
Share Issue/Capital Change
2025
Nov 28
Major Shareholding Notification
2025
Nov 27
Major Shareholding Notification
2025
Nov 14
Capital/Financing Update
2025
Nov 13
